These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1214 related items for PubMed ID: 21968092

  • 1. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 2. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [Abstract] [Full Text] [Related]

  • 3. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Oct; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M, Arihiro S, Miyashita F, Yamamoto H, Yamada N, Nagatsuka K, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2013 Oct; 36(4):299-305. PubMed ID: 24135558
    [Abstract] [Full Text] [Related]

  • 5. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M, Tütüncü S, Fiebach JB, Scheitz JF, Audebert HJ, Nolte CH.
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [Abstract] [Full Text] [Related]

  • 6. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.
    J Stroke Cerebrovasc Dis; 2011 May; 20(2):124-30. PubMed ID: 20598579
    [Abstract] [Full Text] [Related]

  • 7. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K, Iguchi Y, Shibazaki K, Kobayashi K, Uemura J, Aoki J, Yamashita S, Terasawa Y, Matsumoto N.
    J Neurol Sci; 2008 Jul 15; 270(1-2):48-52. PubMed ID: 18304581
    [Abstract] [Full Text] [Related]

  • 8. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G.
    J Stroke Cerebrovasc Dis; 2013 Aug 15; 22(6):703-8. PubMed ID: 22133742
    [Abstract] [Full Text] [Related]

  • 9. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC, Masjuan J, Egido JA, Fuentes B, Simal P, Díaz-Otero F, Reig G, Díez-Tejedor E, Gil-Nuñez A, Vivancos J, Alonso de Leciñana M.
    Cerebrovasc Dis; 2012 Aug 15; 33(3):231-9. PubMed ID: 22261670
    [Abstract] [Full Text] [Related]

  • 10. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):543-9. PubMed ID: 24046398
    [Abstract] [Full Text] [Related]

  • 11. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M, HARP Registry Study Group.
    J Stroke Cerebrovasc Dis; 2015 Dec 01; 24(12):2747-53. PubMed ID: 26360972
    [Abstract] [Full Text] [Related]

  • 12. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2013 May 01; 22(4):545-9. PubMed ID: 23453555
    [Abstract] [Full Text] [Related]

  • 13. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
    Takahashi W, Moriya Y, Mizuma A, Uesugi T, Ohnuki Y, Takizawa S.
    J Stroke Cerebrovasc Dis; 2013 Nov 01; 22(8):e528-32. PubMed ID: 23830955
    [Abstract] [Full Text] [Related]

  • 14. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K, Churilov L, Weir L, Dong Q, Davis S, Yan B.
    J Stroke Cerebrovasc Dis; 2014 Mar 01; 23(3):427-32. PubMed ID: 23635920
    [Abstract] [Full Text] [Related]

  • 15. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
    Mori E, Minematsu K, Nakagawara J, Yamaguchi T, Japan Alteplase Clinical Trial (J-ACT) Group.
    J Stroke Cerebrovasc Dis; 2011 Nov 01; 20(6):517-22. PubMed ID: 20719535
    [Abstract] [Full Text] [Related]

  • 16. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R, Yasunaga H, Kakuda W, Matsui H, Fushimi K, Abo M.
    Cerebrovasc Dis; 2016 Nov 01; 42(1-2):41-8. PubMed ID: 26986718
    [Abstract] [Full Text] [Related]

  • 17. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Nov 01; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 18. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC, Sung SF, Ong CT, Wu CS, Su YH.
    Acta Neurol Taiwan; 2009 Mar 01; 18(1):14-20. PubMed ID: 19537569
    [Abstract] [Full Text] [Related]

  • 19. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
    Endo K, Koga M, Sakai N, Yamagami H, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Toyoda K, Joint Research Group from JR-NET2 and SAMURAI Study Investigators.
    J Stroke Cerebrovasc Dis; 2013 Aug 01; 22(6):805-10. PubMed ID: 22721823
    [Abstract] [Full Text] [Related]

  • 20. Acute stroke management in the elderly.
    Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.
    Cerebrovasc Dis; 2007 Aug 01; 23(4):304-8. PubMed ID: 17199089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.